Fluorescence properties of metoclopramide and its determination in pharmaceutical dosage forms. 1978

W Baeyens, and P De Moerloose

UI MeSH Term Description Entries
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence

Related Publications

W Baeyens, and P De Moerloose
April 2006, Pakistan journal of pharmaceutical sciences,
W Baeyens, and P De Moerloose
January 1991, Journal of pharmaceutical and biomedical analysis,
W Baeyens, and P De Moerloose
July 2009, International journal of pharmaceutics,
W Baeyens, and P De Moerloose
July 1970, Journal of pharmaceutical sciences,
W Baeyens, and P De Moerloose
June 2001, Journal of pharmaceutical and biomedical analysis,
W Baeyens, and P De Moerloose
May 1994, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!